1.Date of occurrence of the event:2023/11/06
2.Company name: OBI Pharma, Inc.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”): head office
4.Reciprocal shareholding ratios: NA
5.Cause of occurrence:
The change of the Company’s business address was approved by the Board of Directors. The information is announced as follows:
Address before change: 19 F., No. 3, Yuanqu St., Nangang Dist., Taipei City 115, Taiwan (R.O.C.)
Address after change: 6 F., No. 508, Sec. 7, Zhongxiao E. Rd., Nangang Dist., Taipei City 115, Taiwan (R.O.C.)
6.Countermeasures: Change registration with the competent authority in accordance with the law.
7.Any other matters that need to be specified(the information disclosure also meets the requirements of Article 7, subparagraph 9
of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of
the securities on public companies.): NA